13 Best Biotech Stocks To Buy Under $20
In this article, we're going to take a look at 13 best biotech stocks to buy under $20.
Day One Biopharmaceuticals Inc. (DAWN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 7,809,852 | $129,018,755 | 1.64% | |
| 2. | Viking Global Andreas Halvorsen | 2,558,563 | $42,267,461 | 0.15% | |
| 3. | Braidwell LP Alex Karnal | 2,173,704 | $35,909,590 | -49% | 1.15% |
| 4. | Deerfield Management James E. Flynn | 1,765,312 | $29,162,954 | +1% | 0.5% |
| 5. | Estuary Capital Andrew Warford | 1,611,137 | $26,615,983 | +83% | 10.81% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.97 | 111,387 | Large Shareholder | 12,929,322 | 2023-10-20 | Filing | |
| $10.06 | 384,400 | Large Shareholder | 12,817,935 | 2023-10-19 | Filing | |
| $10.21 | 979,667 | Large Shareholder | 12,433,535 | 2023-10-18 | Filing | |
| $13.00 | 769,230 | Large Shareholder | 11,453,868 | 2023-06-09 | Filing | |
| $15.00 | 766,667 | Large Shareholder | 766,667 | 2022-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.37 | 10,000 | 1,164,662 | 2024-05-10 | Filing | ||
| $17.85 | 9,154 | 642,602 | 2024-05-03 | Filing | ||
| $17.94 | 6 | 651,756 | 2024-05-02 | Filing | ||
| $17.88 | 70,051 | 651,762 | 2024-05-01 | Filing | ||
| $17.85 | 8,078 | 217,293 | 2024-05-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,608,394 | $111,082,552 | 13.22% | |
| 2. | 5,126,071 | $74,840,637 | 0% | |
| 3. | 4,769,746 | $69,638,291 | 0% | |
| 4. | 4,236,795 | $61,857,203 | 0.02% | |
| 5. | 3,968,166 | $57,935,227 | 0% |
News See All
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
25 Biggest Stocks with Negative Beta
Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.
5 Stocks with Biggest Upside Potential According to Analysts
In this article, we will take a look at the 5 stocks with biggest upside potential according to analysts.
Hedge Fund and Insider Trading News: Ken Griffin, Cliff Asness, Ray Dalio, Sanjay Shah, Brookfield Asset Management, Savara Inc (SVRA), Day One Biopharmaceuticals, Inc. (DAWN), and More
Ken Griffin is moving Citadel’s headquarters to Miami, leaving its current home of Chicago after the billionaire decried the city’s crime rate and voiced frustrations with political leadership in ...
Billionaire Hedge Funds
